CIK 0001091596 · Non-accelerated filer<br>Smaller reporting company
Nuo Therapeutics, Inc.
Sign in to watch- Ticker
- AURX
- Exchange
- OTC
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 233011702
- Phone
- 832-236-9060
- Business address
- 8285 EL RIO, SUITE 190, HOUSTON, TX, 77054
- Former names
- Nuo Therapeutics, Inc, CYTOMEDIX INC, AUTOLOGOUS WOUND THERAPY INC, AUTOLOGOUS WOUND TRERAPY INC
- Open-market buys, last 90 days
- $9,539
- in 1 filing
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,539. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2018-12-31 | Mintz Paul Director | Option exercise · Option to purchase common stock | −50,000 | 0 | ||
| 2018-12-31 | Pittman Scott M. Director | Option exercise · Option to Purchase Common Stock | −62,500 | 0 | ||
| 2018-12-31 | Atinsky Lawrence Director | Grant or award · Option to Purchase Common Stock | +62,500 | 62,500 | ||
| 2018-12-31 | Mintz Paul Director | Grant or award · Option to Purchase Common Stock | +50,000 | 50,000 | ||
| 2018-12-31 | Pittman Scott M. Director | Grant or award · Option to Purchase Common Stock | +62,500 | 62,500 | ||
| 2018-12-31 | CLAUSEN PETER CSO | Grant or award · Option to Purchase Common Stock | +81,250 | 81,250 | ||
| 2018-12-31 | WINZER C ERIC Director | Grant or award · Option to Purchase Common Stock | +68,750 | 68,750 | ||
| 2018-08-09 | WINZER C ERIC Director | Option exercise · Option to purchase common stock | −120,313 | 0 | ||
| 2018-08-09 | WINZER C ERIC Director | Option exercise · Option to purchase common stock | −120,313 | 0 | ||
| 2018-08-09 | Mintz Paul Director | Option exercise · Option to purchase common stock | −87,500 | 0 | ||
| 2018-08-09 | JORDEN DAVID EMERSON CEO/CFO | Option exercise · Option to purchase common stock | −192,710 | 0 | ||
| 2018-08-09 | CLAUSEN PETER CSO/COO | Option exercise · Option to purchase common stock | −183,853 | 0 | ||
| 2018-08-09 | Pittman Scott M. Director | Option exercise · Option to Purchase Common Stock | −121,875 | 0 | ||
| 2018-08-09 | Pittman Scott M. Director | Grant or award · Option to Purchase Common Stock | +121,875 | 121,875 | ||
| 2018-08-09 | Atinsky Lawrence Director | Grant or award · Option to Purchase Common Stock | +109,375 | 109,375 | ||
| 2018-08-09 | JORDEN DAVID EMERSON CEO, CFO | Grant or award · Option to Purchase Common Stock | +192,710 | 192,710 | ||
| 2018-08-09 | WINZER C ERIC Director | Grant or award · Option to Purchase Common Stock | +120,313 | 120,313 | ||
| 2018-08-09 | CLAUSEN PETER CSO | Grant or award · Option to Purchase Common Stock | +183,853 | 183,853 | ||
| 2018-08-09 | Mintz Paul Director | Grant or award · Option to Purchase Common Stock | +87,500 | 87,500 | ||
| 2017-09-11 | Boyalife Investment Fund I, Inc. 10% owner | Purchase | +3,150,000 | $0.22 | $700K | 4,900,000 |
Page 6 of 17 · 326 trades